glp 1 and iih Impact of GLP-1 receptor agonists on idiopathic intracranial hypertension clinical neurosurgical outcomes: a propensity-matched multi-institutional cohort study in: Journal of Neurosurgery Volume 143 Issue 4 (2025) Journals GLP-1 medications and pseudotumor cerebri

Peptides May Be Preferred When: You want to preserve natural testosterone production and HPG axis function Fertility is a current or future concern Testosterone levels are mildly to moderately low (300-500 ng/dL) Symptoms are present but not severely impacting quality of life You prefer a therapy that works with your bodys natural systems You are interested in the additional benefits of GH optimization alongside testosterone support TRT May Be Preferred When: Testosterone levels are severely low (below 250 ng/dL) Symptoms are significantly impacting daily function and quality of life Primary hypogonadism (testicular failure) is the diagnosis, where the testes cannot respond to stimulation Faster and more predictable results from testosterone therapy are clinically important Previous peptide therapy has not produced adequate improvement In some cases, a combined approach using both peptides and TRT may be optimal

Immune dysregulation The pathogenesis of RA is intricately linked to the human immune system and involves elevated levels of immune cells and molecules in the synovial tissue and fluid of RA patients [60]

The primary outcome was defined as a change in the irritability subscale score

The intravenous safety study published in 2025 involved only 2 participants

Is Oral Omega-3 Effective in Reducing Mucocutaneous Side Effects of Isotretinoin in Patients with Acne Vulgaris

A randomized, phase 3 trial of naltrexone SR/bupropion SR for weight loss in obesity